| 488928 |
NEURO-ONCOLOGY |
GENE-35. MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED LGG AS A POTENTIAL BIOMARKER FOR TMZ-ASSOCIATED HYPERMUTATION AT RECURRENCE | GENE-35. MGMT PROMOTER METHYLATION IN NEWLY DIAGNOSED LGG AS A POTENTIAL BIOMARKER FOR TMZ-ASSOCIATED HYPERMUTATION AT RECU |
2019-11-01 |
10.1093/neuonc/noz175.437 |
Mathur Radhika, Zhang Yalan, Grimmer Matthew, Hong Chibo, Berger Mitchel, Molinaro Annette, Ann Oberheim-Bush Nancy, Chang Susan, Costello Joseph |
| 488927 |
NEURO-ONCOLOGY |
CBMT-22. REVERSING THE WARBURG EFFECT BY TARGETING NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT), THE RATE-LIMITING ENZYME OF NAD+ SALVAGE PATHWAY INCREASES, CHEMOSENSITIVITY TO TEMOZOLOMIDE IN GLIOMA CELLS | CBMT-22. REVERSING THE WARBURG EFFECT BY TARG |
2019-11-01 |
10.1093/neuonc/noz175.144 |
Sharma Pratibha, Senapedis William, Sampath Deepa, Puduvalli Vinay |
| 488926 |
NEURO-ONCOLOGY |
NIMG-06. OUR THERAPEUTIC STRATEGIES FOR GLIOBLASTOMA: INTRAOPERATIVE SUPPORT SYSTEMS [INTRAOPERATIVE MRI, PET, 5-AMINOLEVULINIC ACID (5-ALA)] AND NEOADJUVANT CHEMOTHERAPY |
2019-11-01 |
10.1093/neuonc/noz175.678 |
Miyake Keisuke, Ogawa Daisuke, Okada Masaki, Hatakeyama Tetsuhiro, Tamiya Takashi |
| 488925 |
NEURO-ONCOLOGY |
QOLP-03. MEASURING CHANGE IN HEALTH-RELATED QUALITY OF LIFE: THE ADDED VALUE OF ANALYSIS ON THE INDIVIDUAL PATIENT LEVEL IN GLIOMA PATIENTS IN CLINICAL DECISION MAKING |
2019-11-01 |
10.1093/neuonc/noz175.823 |
Coomans Marijke, Taphoorn Martin, Aaronson Neil, Baumert Brigitta, van den Bent Martin, Bottomley Andrew, Brandes Alba, Chinot Olivier, Coens Corneel, Gorlia Thierry, Herrlinger Ulrich, Keime-Guibert Florence, Malmström Annika, Martinelli Francesca, Stupp Roger, Talacchi Andrea, Weller Michael, Wick Wolfgang, Reijneveld Jaap |
| 488924 |
NEURO-ONCOLOGY |
TMOD-40. IN VIVO EVALUATION OF O6-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER METHYLATION STATUS FOR DE NOVO GLIOBLASTOMA PATIENTS USING DEEP LEARNING FEATURES | TMOD-40. IN VIVO EVALUATION OF O6-METHYLGUANINE-DNA-METHYLTRANSFERASE (MGMT) PROMOTER |
2019-11-01 |
10.1093/neuonc/noz175.1139 |
Rathore Saima, Nasrallah MacLean, Akbari Hamed, Shukla Gaurav, Bagley Stephen, Watt Christopher, Min Ha Sung, Mamourian Elizabeth, Sako Chiharu, Binder Zev, O’Rourke Donald, Davatzikos Christos |
| 488923 |
대한신경외과학회지 |
Risk Factors and Preoperative Risk Scoring System for Shunt-Dependent Hydrocephalus Following Aneurysmal Subarachnoid Hemorrhage |
2019-11-01 |
10.3340/jkns.2018.0152 |
Kim, Joo Hyun, Kim, Jae Hoon, Kang, Hee In, Kim, Deok Ryeong, Moon, Byung Gwan, Kim, Joo Seung |
| 488922 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Outcome of Deferred Revascularization in Patients Using Fractional Flow Reserve Over 1 Year Follow-Up |
2019-11-01 |
10.1016/j.ihj.2019.11.159 |
Shaik S.A., Maddury J. |
| 488921 |
INDIAN HEART JOURNAL : OFFICIAL PUBLICATION OF THE CARDIOLOGICAL SOCIETY OF INDIA |
Incremental Role of Global Longitudinal Strain , QRS- T Angle and CMR - Documented Myocardial Fibrosis in Reclassifying Risk for Patients with Ventricular Arrhythmias in HCM/ HOCM – First Study from the Subcontinent |
2019-11-01 |
10.1016/j.ihj.2019.11.126 |
Kinni P., Dash P.K. |
| 488920 |
BMJ OPEN |
Examining risk factors for self-harm and suicide in LGBTQ+ young people: a systematic review protocol |
2019-11-01 |
10.1136/bmjopen-2019-031541 |
Williams A Jess, Arcelus Jon, Townsend Ellen, Michail Maria |
| 488919 |
ONCOLOGY LETTERS |
Reduced expression of microRNA‑139‑5p in hepatocellular carcinoma results in a poor outcome: An exploration the roles of microRNA‑139‑5p in tumorigenesis, advancement and prognosis at the molecular biological level using an integrated meta‑analysis and bi |
2019-11-01 |
10.3892/ol.2019.11031 |
Qin Hui, Wen Dong‑Yue, Que Qiao, Zhou Chuan‑Yang, Wang Xiao‑Dong, Peng Yu‑Ting, He Yun, Yang Hong, Liao Bo‑Ming |
